Introduction
============

Limbal stem cell deficiencies cause conjunctival epithelial ingrowth, neovascularization, chronic inflammation, recurrent epithelial erosions and defects, destruction of the basement membrane, and fibrous tissue ingrowth, leading to severe functional impairment ([@b54-co-1-373]; [@b57-co-1-373]; [@b28-co-1-373]). The pathology includes Stevens-Johnson syndrome, ocular cicatricial pemphigoid, chemicals and thermal burns and radiation injury.

Proper visual function requires an intact ocular surface. The integrity of the corneal surface is maintained by two specialized epithelia, the conjunctival epithelium and the limbal corneal epithelium. Corneal epithelial stem cells reside in the palisades of Vogt, located in the basal layer of the limbus, coinciding with the transitional zone between the cornea and the bulbar conjunctiva ([@b45-co-1-373]; [@b10-co-1-373]). Limbal stem cells produce undifferentiated progeny with limited proliferative potential that migrate centripetally from the periphery of the corneal epithelium to replace cells desquamating during normal cell turnover ([@b24-co-1-373]; [@b5-co-1-373]; [@b27-co-1-373]; [@b3-co-1-373]; [@b30-co-1-373]; [@b9-co-1-373]; [@b36-co-1-373]).

Conventional corneal transplantation, which replaces the central part of the cornea with the same part from a donor cornea, is used to treat diseases such as keratoconus with intact limbal stem cells; however, conventional corneal transplantation is not applicable for patients with limbal stem cell deficiency. In those cases, the donor cornea is rejected and the cornea is covered by cells migrating from the recipient's conjunctival epithelium. A series of events leads to functional blindness. To prevent this conjunctival invasion of the corneal surface, restoration of the limbus is required. Recently, corneal regeneration therapy made dramatic progress and is already in clinical practice.

In this article, we summarize recent advances in corneal regeneration therapies and report the possible application of epithelial cells derived from embryonic stem (ES) cells for surface reconstruction of the damaged cornea.

Efforts to identify corneal epithelial stem cells
=================================================

The integrity of the ocular surface is maintained by the centripetal migration of transient amplifying cells derived from limbal stem cells. Transient amplifying cells are present in the corneal epithelia and are committed to epithelial differentiation with limited proliferative potential ([Figure 1](#f1-co-1-373){ref-type="fig"}). The rapidly proliferating transient amplifying cells undergo terminal differentiation accompanied by loss of their proliferative potential.

Limbal stem cells are normally slow cycling cells. When activated by wounding or by in vitro culture conditions, they grow and regenerate the tissue with high proliferative potential ([@b52-co-1-373]; [@b5-co-1-373]; [@b10-co-1-373]). Limbal stem cells lack corneal epithelial differentiation-associated markers, such as cytokeratin 3 ([@b45-co-1-373]), and have highly mitotic ability in vitro ([@b15-co-1-373]).

Cytokeratins are intermediate filamentous proteins expressed by epithelial cells. A large number of cytokeratin proteins have been identified, each with a specific expression pattern in different epithelial cells. Cytokeratin 12 and cytokeratin 3 are expressed in differentiated and stratified corneal epithelium, although the relative expression of each appears to vary between species. Conjunctiva epithelia express mainly cytokeratin 5 and cytokeratin 14 in their basal layers. On the ocular surface, it is important to distinguish the corneal epithelia from conjunctival epithelia, because, during the healing of corneal epithelial wounds with limbal cell deficiency, conjunctival epithelium often migrates across the denuded limbus to cover the corneal surface ([@b47-co-1-373]; [@b54-co-1-373]; [@b14-co-1-373]), causing a pronounced decrease in visual acuity.

Specific markers for limbal stem cells have not been identified. Recently, many types of tissue-specific stem cells have been shown to exhibit a side population phenotype, defined by their unique ability to efflux the DNA binding dye Hoechst 33342 ([@b17-co-1-373]; [@b51-co-1-373]). Side population cells are small size and exclude Hoechst 33342 dye with blue and red fluorescence from the cell body. Thus, side population cells lack blue and red fluorescence when analyzed by flow cytometer ([Figure 2](#f2-co-1-373){ref-type="fig"}). The side population phenotype is largely determined by expression of the ATP-binding cassette, sub-family G, and member2 (ABCG2), a member of the multiple drug resistance (MDR) family of membrane transporters ([@b64-co-1-373]; [@b29-co-1-373]). ABCG2 is reported to contribute to the side population phenotype in cells from various cell sources, including hematopoietic stem cells. Using fluorescence-activated cell sorting with Hoechst 33342 dye staining, approximately 0.3%--0.5% of limbal epithelial cells exhibit the side population phenotype in humans, whereas no side population cells have been identified in the central corneal epithelium ([@b62-co-1-373], [@b63-co-1-373]); therefore, it was suggested that ABCG2-positive limbal epithelial cells may include putative limbal stem cells ([@b62-co-1-373]).

Transcription factor p63 is a member of the p53 family, and is essential for epithelial development and differentiation. p63 has been considered a potential marker of stem/progenitor cells in ocular tissue ([@b43-co-1-373]). It has been hypothesized that p63 may be an earlier marker of limbal stem cells. p63 is highly expressed in the nuclei of limbal basal cells but not in the corneal epithelium ([@b41-co-1-373]). In addition, it has been demonstrated that p63 expression is gradually reduced from basal cells to terminally differentiated corneal epithelial cells ([@b13-co-1-373]; [@b43-co-1-373]). These findings suggested that p63-positive cells may include limbal stem cells. In any event, the identification and isolation of limbal stem cells may contribute largely to reconstruction of the ocular surface because long-term, functional recovery of the corneal epithelium is linked to graft constructs that retain viable stem cell populations.

Development of corneal regeneration therapies
=============================================

Several ophthalmologists have succeeded in the clinical transplantation of grafts generated from expanded limbal stem cells to treat patients with limbal stem cell deficiencies ([@b42-co-1-373]; [@b56-co-1-373]; [@b25-co-1-373]; [@b44-co-1-373]; [@b38-co-1-373]). The methods involve the following two major approaches, allograft transplantation and autologous limbal transplantation ([Figure 3](#f3-co-1-373){ref-type="fig"}).

Allograft transplantation is performed in patients with unilateral or bilateral deficiencies ([@b25-co-1-373]). The limbal stem cells obtained by biopsy were forced to proliferate sufficiently in the ex vivo culture and the cell sheet made of the expanded limbal stem cells was transplanted to the damaged cornea. Transient amplifying cells are supplied continuously from the donor limbus, and thus corneal limbal epithelium is formed largely by transient amplifying cells in the recipient cornea ([@b30-co-1-373]; [@b59-co-1-373]); however, this procedure carries risks of immunologic rejection and infection of unidentified organisms. Graft failure usually occurs, even with continuous immunosuppression, owing to serious pre-operative conditions such as persistent inflammation of the ocular surface, severe dry eye and lid related abnormalities ([@b50-co-1-373]).

Transplantation of autologous limbal stem cell sources is an alternative to allograft transplantation and does not require immunosuppression ([@b42-co-1-373]; [@b38-co-1-373]). Autologous limbal transplantation is a method of surface reconstruction of the cornea in patients with unilateral total deficiency of limbal stem cells ([@b21-co-1-373]; [@b55-co-1-373]; [@b34-co-1-373]); however, this procedure requires a large limbal graft from the healthy eye (usually 30%--40% of the donor limbs) ([@b6-co-1-373]). Corneal cell sheets used as grafts were prepared from ex vivo culture of the autologous limbal stem cells; however, grafts lacking a structural basement membrane and extracellular matrix system were fragile and had problems with the decrease of cell to matrix adhesion. Therefore, several researchers have developed autologous cultivated corneal epithelial stem cell sheets using the amniotic membrane, fibrin gel and a temperature-sensitive cell culture surface as a carrier of the cell sheets. ([@b58-co-1-373]; [@b18-co-1-373]; [@b46-co-1-373]; [@b56-co-1-373]; [@b25-co-1-373]; [@b44-co-1-373]; [@b48-co-1-373]; [@b37-co-1-373]; [@b39-co-1-373]). These procedures use biological materials and synthetic polymers to cultivate transplantable sheets. The amniotic membrane supports the proliferation and differentiation of limbal stem cells ([@b22-co-1-373]). Cells cultured on the amniotic membrane showed significantly reduced vascularization and inflammation by comparison with other carriers of sheets. Immunoreaction may be suppressed by using the amniotic membrane, because the amniotic membrane expresses incomplete HLA-A, B, C and DR antigens, which may account for the fact that immunological rejection after transplantation has not been observed in this method ([@b1-co-1-373]). Collectively, cells cultured on the amniotic membrane are suitable for transplantation and are easy to handle. These results revealed that the amniotic membrane is applicable as a carrier of corneal epithelial cell sheets. This method (autologous cultivated corneal epithelial stem cell sheets using the amniotic membrane) can not be applied for bilateral total limbal stem cell deficiency such as Stevens-Johnson and ocular cicatricial pemphigoid. In addition, there is a possibility of infection by an unidentified microorganism.

Recently, autologous epithelial cell sheets were developed by culturing a patient's oral mucous membrane on temperature-sensitive culture surfaces and were successfully transplanted to the damaged cornea ([@b40-co-1-373]). Temperature-sensitive culture surfaces allow oral mucousal epithelial cells to interact directly with a recipient's ocular surface without interference from cell carriers such as fibrin gel and the amniotic membrane. After transplantation and adaptation to the recipient's microenvironment, the grafted oral mucosal epithelial cells expressed cytokeratin 3; however, they did not express cytokeratin 12. These findings suggest that oral mucousal epithelial cells do not differentiate fully to authentic corneal epithelial cells. If oral mucosa membranes are damaged in systematic diseases such as Stevens-Johnson syndrome, it is hard to recover oral mucosal epithelial cells to make cell sheets.

The most important key to realizing the reconstruction is a sufficient supply of the cells/materials needed for transplantation; therefore, we have focused our attention on ES cells, because ES cells proliferate indefinitely and may provide sufficient numbers of epithelial cells for corneal transplantation.

ES cells as a new cell source of corneal epithelial cell transplantation
========================================================================

Stem cells are the primary cells common to all multicellular organisms that maintain the ability of renewal through cell division, and differentiate into a wide range of specialized cell types. Recent stem cell researches indicated their huge potential as a source of tissue for regenerative medicine. Stem cells may be obtained from embryonic tissues, umbilical cord blood, and some differentiated adult tissues; however, adult stem cells preferentially generate differentiated cells of the same lineage as their tissue of origin.

The most primitive cell is the fertilized egg. The fertilized egg and the descendants of the first two cell divisions are totipotent, and are able to form the embryo and the trophoblasts of the placenta. After about four days, these totipotent cells begin to differentiate into blastocysts ([Figure 4](#f4-co-1-373){ref-type="fig"}). ES cells are cultures of cells derived from epiblast tissue of the inner cell mass (ICM) of a blastocyst ([@b2-co-1-373]; [@b11-co-1-373]). ES cells are isolated by transferring the inner cell mass into a plastic culture dish that contains a nutrient culture medium. After propagation culture, ES cells were established. ES cells are pluripotent cells; they have the ability to differentiate into any cell type of all three germ layers as ectoderm, mesoderm, and endoderm cells, including corneal epithelial progenitors.

ES cells develop into each of the more than 200 cell types of the adult body when given sufficient and necessary stimulation for specific cell-type differentiation ([Figure 5](#f5-co-1-373){ref-type="fig"}). When ES cells are given no stimuli for differentiation, they continue to divide in vitro for a long time and each daughter cell remains pluripotent; therefore, ES cells are a valuable cell source for regenerative medicine and tissue replacement after injury and disease ([@b23-co-1-373]; [@b4-co-1-373]). After transplantation, ES-derived cells have the potential to replace host cells lost during injury and disease. Alternatively, ES-derived cells supply host tissues with therapeutic factors leading to a functional benefit. Medical researchers who are studying ES cell differentiation anticipate treating a wide variety of diseases including leukemia, Parkinson's disease, spinal cord injuries, and muscle damage, amongst a number of other impairments and conditions ([@b31-co-1-373]; [@b16-co-1-373]). Mouse ES cells are commonly used in basic research field, because they are easy to transfect with a specific gene and perform gene knock out.

In 1998, Dr. Thomson reported the culture of human ES cells, and the production of all kinds of cells and tissues derived from ES cells for transplantation has logically become a reality ([@b53-co-1-373]); however, ES cell research is ethically controversial, because an ES cell line is made from an extra fertilized ovum used in infertility therapy. Many nations currently have a moratorium on either ES cell research or the production of new ES cell lines.

Previously, we have reported induction of the differentiation of mouse ES cells into corneal epithelial progenitor cells by culturing them on type IV collagen and successful reconstruction of the damaged cornea by transplantation of ES cell-derived epithelial progenitor cells ([@b19-co-1-373]). In general, the presence of substrates or basement membranes is necessary to support normal differentiation of corneal epithelial cells. Type IV collagen is the basic structural component of all basement membranes and forms the backbone to which other basement membrane components attach ([@b8-co-1-373]). The cornea is initially covered with an epithelium that attaches to the normal basement membrane during eye development ([@b8-co-1-373]); therefore, we used type IV collagen as a substitution substrate of the basement membrane. Undifferentiated ES cells were collected from the maintenance culture consisting of leukemia inhibitor factor and mouse embryonic fibroblasts as feeder cells. ES cells were cultured on cell culture dishes for four days to make embryoid bodies. The embryoid bodies were transferred to dishes coated with type IV collagen. Cells cultured on type IV collagen began to form an epithelium-like monolayer at day 8 of culture. These cells expressed pax6 and cytokeratin 12, both of which are markers of corneal epithelial cell differentiation ([@b32-co-1-373]; [@b35-co-1-373]). They did not express cytokeratin 14, a marker of conjunctival epithelial cells. This suggested that pax6 and other signals necessary for the appropriate differentiation of corneal epithelial cells from ES cells were provided by their interaction with type IV collagen.

Next, we transplanted these cells. After corneal surface injury with *n*-heptanol, these cells were transplanted to the injured cornea ([@b7-co-1-373]; [@b54-co-1-373]). At 24 hours after transplantation, histological examination of the eyes disclosed that the grafted cells adhered tight to the recipient corneal stroma and completely covered the damaged corneal surface ([Figure 6](#f6-co-1-373){ref-type="fig"}). We have not noted the development of teratoma. We concluded that ES cell-derived epithelial progenitor cells were applicable for corneal epithelial cell transplantation.

With our method, approximately 20% of undifferentiated ES cells cultured on type IV collagen differentiated into corneal epithelial progenitor cells. This result means that the purity of the corneal epithelial cells induced by our culture protocol was not satisfactory. To yield purified corneal epithelial cells, transfer of a gene that promotes corneal epithelial cell differentiation into ES cells is a promising technology. The pax6 transcription factor is a member of the pax gene transcription factor family ([@b61-co-1-373]) and is known to function during early embryogenesis to control key steps in ocular system development ([@b9-co-1-373]). In particular, pax6 is required not only for embryonic development but also for postnatal development and maintenance of the adult cornea ([@b12-co-1-373]). Pax6 protein is localized to the nuclei of epithelium, but neither stromal nor endothelial cells of the cornea ([@b26-co-1-373]). Pax6 has been shown to activate corneal gene promoters for cytokeratin 12 ([@b33-co-1-373]; [@b49-co-1-373]); thus, pax6 is considered a master regulator of eye development.

To obtain highly purified corneal epithelial cells, we introduced the pax6 gene to mouse ES cells ([@b20-co-1-373]). The pax6 gene in combination with green fluorescence protein (GFP) and neomycin-resistant gene was electrotransfected to ES cells, and the transfected cells were cultivated with antibiotic neomycin for 14 days. Neomycin selection culture enables us to purify cells which have taken up the pax6 gene. After neomycin selection, pax6-transfected cells formed a monolayer of cells and demonstrated an epithelial cell-like appearance. We found that the efficiency of inducing corneal epithelial cells with the pax6 transfection method is higher than that by culturing on type IV collagen. We then transplanted pax6-transfected cells onto damaged cornea ([@b60-co-1-373]). The pax6-transfected cells formed bilayers of epithelial cells that were GFP-positive 24 hours after transplantation. The injury-induced detachment of corneal epithelial layers caused swelling of the corneal stroma, whereas transplantation of pax6-transfected cells reduced the swelling and inflammatory cell infiltration of the corneal stroma was subsided. The pax6-transfected cells expressed cytokeratin 12 at the grafted site. Contamination of other germ cells and teratoma were not detected. Thus, the highly purified corneal epithelial cells derived from pax6-transfected ES cells survived on the injured cornea. The cells restored the damaged cornea histologically and functioned as native corneal epithelial cells because they suppressed corneal epithelial damage-induced inflammation. As the next step to clinical application, we have started to culture cynomolgus monkey ES cells for the induction of corneal epithelial cells. Cynomolgus monkey ES cells share many characteristics with human ES cells, and resemble human ES cells more than mouse ES cells. Cynomolgus monkey ES cells preferentially differentiated into corneal epithelial-like cells in vitro ([Figure 7](#f7-co-1-373){ref-type="fig"}).

In summary, we have shown the establishment of corneal epithelial cell differentiation of mouse ES cells and cynomolgus monkey ES cells. We hope that human ES-derived epithelial cells may become applicable for surface reconstruction of damaged corneas in the near future.
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![Schematic representation of corneal epithelial cells. The ocular surface is composed of three epithela, conjunctival, limbal and corneal. Limbal stem cells are located in the palisades of Vogt, the transitional zone between the cornea and the conjunctiva. Limbal stem cells are close to blood vessels. They generate transient amplifying cells that terminally differentiate after a discrete number of cell divisions to corneal epithelial cells and undergo both centripetal migration and vertical migration.](opth-1-373f1){#f1-co-1-373}

![Schematic representation of the side population cells analyzed by flow cytometry. Rat limbal stem cells were treated with Hoechst 33342 dye and were analyzed by flow cytometry. A population of cells with low Hoechst 33342 blue/red fluorescence was isolated as side population cells in the limbus. Non-side population cells accompanying high Hoechst 33342 blue/red fluorescence formed a distinct cell population.](opth-1-373f2){#f2-co-1-373}

![Corneal regeneration by using cell sheets made of cultured corneal epithelial cells. Several cell sources which include limbal stem cells are applicable to form epithelial cell sheets for treating patients with limbal stem cell deficiencies. Limbal stem cells are obtained from a healthy area of a patient's injured cornea (autologous limbal epithelium). Allogeneic limbal epithelium and autologous limbal epithelium of a patient's contralateral normal cornea are similarly applicable. After culturing on fibrin gel, the amniotic membrane and a temperature-sensitive cell culture surface, these cells formed cell sheets, which were then transplanted onto the damaged cornea. Successful application of a patient's oral mucous membrane was reported. Oral epithelium is used as an alternative to the limbal epithelium when the patient has severe bilateral limbal stem cell deficiency.](opth-1-373f3){#f3-co-1-373}

![Establishment of ES cells from fertilized egg. ES cells are derived from embryos developed from eggs that have been fertilized in vitro. Human ES cells are typically four or five days old and are a hollow microscopic ball of cells called a blastocyst. The inner cell mass of the blastocyst is collected and cultured on a feeder cell layer. After several passages, the cells are established as ES cells.](opth-1-373f4){#f4-co-1-373}

![Differentiation of ES cells which give rise to several descendants. ES cells are pluripotent, and give rise during development to all derivatives of the three primary germ layers: endoderm, mesoderm and ectoderm.](opth-1-373f5){#f5-co-1-373}

![Transplantation of ES cell-derived corneal epithelial cells onto injured cornea. Mouse cornea was denuded by *n*-heptanol treatment. ES cell-derived epithelial progenitor cells were transplanted to the injured cornea. Histologic analysis was conducted. (**A**) At 24 hours after transplantation, the eyes were enucleated. Cryostat sections were stained with hematoxylin and eosin staining. (**B**) Schematic representation of panel A.](opth-1-373f6){#f6-co-1-373}

![Corneal epithelial progenitor cells differentiated from cynomolgus monkey ES cells in vitro. Inverted microscopic view. ES cells were cultured on cell culture dishes for 4 days to form embryoid bodies, and the embryoid bodies were cultured on type IV collagen for 4 more days. The adhering cells emerged from the embryoid bodies had an epithelial cell-like appearance.](opth-1-373f7){#f7-co-1-373}
